GlucoTrack Stock (NASDAQ:GCTK)


RevenueOwnershipFinancialsChart

Previous Close

$5.87

52W Range

$4.22 - $468.00

50D Avg

$6.28

200D Avg

$8.49

Market Cap

$3.19M

Avg Vol (3M)

$119.47K

Beta

0.30

Div Yield

-

GCTK Company Profile


GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

11

IPO Date

Apr 25, 2013

Website

GCTK Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 19Dec 18
Asia and Pacific$300.00$2.00K
Europe$208.46K$41.49K

Fiscal year ends in Dec 24 | Currency in USD

GCTK Financial Summary


Dec 24Dec 23Dec 22
Revenue---
Operating Income-$-7.10M$-4.43M
Net Income$22.60M$-7.10M$-4.44M
EBITDA-$-7.09M$-4.41M
Basic EPS$0.07$-1.92$-0.29
Diluted EPS$0.07$-1.92$-0.29

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison


TickerCompany
AKANAkanda Corp.
BGMSBio Green Med Solution, Inc.
VEROVenus Concept Inc.
NAOVNanoVibronix, Inc.
INMInMed Pharmaceuticals Inc.
BBLGBone Biologics Corporation
NDRAENDRA Life Sciences Inc.
RDHLRedHill Biopharma Ltd.
DHAIDIH Holding US, Inc.
HSCSHeartSciences Inc.